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Abstract
22q11.2 deletion syndrome (22q11DS)—a neurodevelopmental condition caused by a hemizygous deletion on chromosome
22—is associated with an elevated risk of psychosis and other developmental brain disorders. Prior single-site diffusion
magnetic resonance imaging (dMRI) studies have reported altered white matter (WM) microstructure in 22q11DS, but small
samples and variable methods have led to contradictory results. Here we present the largest study ever conducted of dMRI-
derived measures of WM microstructure in 22q11DS (334 22q11.2 deletion carriers and 260 healthy age- and sex-matched
controls; age range 6–52 years). Using harmonization protocols developed by the ENIGMA-DTI working group, we
identiﬁed widespread reductions in mean, axial and radial diffusivities in 22q11DS, most pronounced in regions with major
cortico-cortical and cortico-thalamic ﬁbers: the corona radiata, corpus callosum, superior longitudinal fasciculus, posterior
thalamic radiations, and sagittal stratum (Cohen’s d’s ranging from −0.9 to −1.3). Only the posterior limb of the internal
capsule (IC), comprised primarily of corticofugal ﬁbers, showed higher axial diffusivity in 22q11DS. 22q11DS patients
showed higher mean fractional anisotropy (FA) in callosal and projection ﬁbers (IC and corona radiata) relative to controls,
but lower FA than controls in regions with predominantly association ﬁbers. Psychotic illness in 22q11DS was associated
with more substantial diffusivity reductions in multiple regions. Overall, these ﬁndings indicate large effects of the 22q11.2
deletion on WM microstructure, especially in major cortico-cortical connections. Taken together with ﬁndings from animal
models, this pattern of abnormalities may reﬂect disrupted neurogenesis of projection neurons in outer cortical layers.
Introduction
22q11.2 deletion syndrome (22q11DS; also known as Velo-
cardiofacial or DiGeorge syndrome) results from a recurrent
1.5–3 megabase (Mb) microdeletion on the long arm of
chromosome 22. It is the most common chromosomal
microdeletion syndrome, with a prevalence of 1 per 3000 to
4000 live births [1, 2]. 22q11DS is associated with a range of
characteristic abnormalities, including cardiac defects, cra-
niofacial anomalies, and intellectual disability [1, 3]. Parti-
cularly, it increases the risk for psychotic illness around 25-
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fold relative to the general population [2, 4–6]. The deletion is
also associated with elevated rates of other developmental
neuropsychiatric disorders [5], but the increased risk for
psychosis in 22q11DS may be the most speciﬁc association,
as it greatly exceeds the roughly threefold increased risk of
psychosis associated with general developmental delay [7, 8].
Notably, mouse models of the 22q11.2 deletion show fewer
neural progenitors of projection neurons in cortical layers 2/3,
which leads to altered connectivity between cortical associa-
tion areas [9]. Hence, 22q11DS is a compelling model to
study genetic causes and neural mechanisms underlying dis-
orders of cortical circuit development, such as schizophrenia.
WM microstructural properties can be quantiﬁed non-
invasively using diffusion magnetic resonance imaging
(dMRI). Fractional anisotropy (FA), a widely used measure of
white matter (WM) microstructural organization, is derived
from a common dMRI reconstruction method, diffusion ten-
sor imaging (DTI), and may reﬂect the coherence and density
of ﬁber tracts in a voxel. Other DTI indices, axial diffusivity
(AD) and radial diffusivity (RD), are also altered in a range of
brain diseases [10]. For example, lower AD can reﬂect axonal
damage and degeneration [11], or smaller axonal diameter
[12]. RD is associated with inter-axonal spacing (i.e., extra-
cellular space) [12]; in animal models, demyelination and
dysmyelination can lead to abnormally high RD [13–15].
Mean diffusivity (MD) is a generalized measure of the
surface-to-volume ratio of cellular membranes [16].
Disturbances in WM microstructural organization have
been frequently reported in 22q11DS; however, studies to
date have been relatively small, with highly variable ﬁndings.
While many studies reported lower FA in 22q11DS compared
to healthy controls (HC) in major WM tracts, including
commissural, association and projection ﬁbers [17–22], sev-
eral others reported higher overall FA [23–25], or mixed
ﬁndings across tracts [26–31]. Most studies reported con-
sistent decreases in DTI-derived diffusivity measures (i.e.,
MD, RD, and AD), although some report mixed results [20]
or higher WM diffusivity in 22q11DS [21, 22]. Supplemen-
tary Table S1 summarizes prior ﬁndings. These contrasting
reports have hindered conclusions regarding the nature of
WM microstructural abnormalities in 22q11DS.
Contrasting ﬁndings in prior studies may also be due to
different analytical techniques, ranging from tract-based
spatial statistics (TBSS [32]) to voxel-wise analyses and
tractometry. This technical variability makes it difﬁcult to
apply traditional meta-analytic approaches that attempt to
combine summary statistics from prior publications.
WM differences associated with psychosis are of interest
in 22q11DS. Psychotic symptoms in 22q11DS have been
associated with higher FA and lower WM diffusivities, but
not always in the same regions across studies
[22, 25, 30, 31, 33, 34]. In addition, there is variability in
deletion breakpoints; 85–90% of individuals with the
deletion have a ~3Mb (A–D) deletion, containing 46
protein-coding genes, whereas ~10% of cases have a nested
1.5 Mb (A–B) deletion [1]. WM differences in 22q11DS
may be due in part to variable deletion size, as deletion size
impacts cortical surface area [35].
To address these uncertainties and determine factors that
affect WM abnormalities in 22q11DS, the 22q11DS Working
Group of the Enhancing Neuroimaging Genetics through
Meta-Analysis Consortium (ENIGMA-22q11DS) performed
a coordinated analysis of the raw dMRI data from ten inde-
pendent studies, and meta-analyzed group differences and
their modulators. We addressed these questions:
(1) Are there consistent group differences in WM
microstructure between 22q11.2 deletion carriers and
demographically matched HC?
(2) Are there differential age effects between groups,
suggesting altered WM development in 22q11DS?
(3) Do 22q11DS participants with a psychotic disorder
show more severe WM alterations, and do these
differences overlap with those found in idiopathic
schizophrenia?
(4) Does deletion size impact DTI indices?
(5) Is WM microstructure related to cognitive abilities, in
22q11DS and in HC?
Methods
Participants
dMRI data were contributed from ten previously collected
studies to be analyzed as part of the ENIGMA-22q11DS
working group. This analysis included 594 participants: 334
with 22q11DS (mean age: 16.88 ± 6.43, 153 females) and 260
HC (mean age: 16.55 ± 8.01, 123 females). Demographic
characteristics are shown in Table 1 and Supplemental
Table S2a, b. Psychotropic medication status at the time of
scanning is included in Supplementary Table S2c. Individual
study details are in Supplemental Table S3. Institutional review
boards at participating institutions approved all study proce-
dures, and material transfer agreements approved any sharing
of de-identiﬁed imaging data. A written informed consent was
obtained from all study participants or a legal guardian.
Measurements of sample-speciﬁc phenotype
characteristics
All sites conducted structured diagnostic interviews at the
time of scanning to determine lifetime psychiatric diag-
noses. Wechsler IQ assessments were used to assess cog-
nitive function (Supplemental Table S3, Supplemental
Methods 1).
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Across sites, deletion size was determined using multi-
plex ligation-dependent probe ampliﬁcation (MLPA) [36].
The large sample size here uniquely allowed for the com-
parison of effects of the two most frequent deletion types,
the longer A–D vs the shorter A–B deletion, on DTI mea-
sures. From cases with available MLPA data, 206 subjects
had the A–D deletion (89.9%), and 15 (6.5%) subjects had
the A–B deletion (see Supplemental Table S3).
Image acquisition and processing
Acquisition parameters of dMRI and T1-weighted MRI
scans for each site are shown in Supplemental Tables S4
and S5. All raw data were preprocessed in an identical
fashion at a single site (Supplemental Methods 2). FA,
MD, RD, and AD maps were skeletonized as described in
the ENIGMA-DTI protocol [37, 38], based on the TBSS
method [32], ensuring that all data are normalized to the
ENIGMA-DTI template. Mean values were calculated for
each DTI measure along the skeleton within each ROI
deﬁned by the Johns Hopkins University WM atlas (JHU-
ICBM-DTI-81) distributed by FSL [37, 39]. For all ana-
lyses, we used the mean of the right and left values for
bilateral ROIs, for each measure; we included the mean of
all WM JHU-ICBM ROIs and we excluded the corti-
cospinal tract, midsagittal fornix region and the hippo-
campal portion of the cingulum bundle as these ROIs are
difﬁcult to reliably register, or were subject to artifacts in
cohorts in this study [40]. The ROIs included are shown in
Fig. 1.
Statistical analyses
Effects of 22q11DS and age on DTI-derived measures
Group differences between 22q11DS and HC were
investigated using two analytic approaches: a meta-
analysis, which runs statistical comparisons for each site
separately and combines the summary statistics across
sites, and a mega-analysis, in which data are harmonized
and pooled from individual subjects, and statistical ana-
lysis is run on the full group. The meta-analysis included
540 subjects: 278 22q11DS probands (mean age: 16.76 ±
6.78, 138 females) and 260 HC (mean age: 16.55 ± 8.01,
123 females) from nine independent datasets derived from
eight sites (Table 1). Because Utrecht included only
22q11DS cases, it was not included in the case-control
analyses. For each site, linear regressions were run, in
which the mean DTI measure for each ROI was the
dependent variable, diagnosis was the predictor of inter-
est, and age, [age-mean(age)]2 and sex were included as
covariates. Given that DTI-derived measures tend to peak
between 11 and 20 years for commissural and association
ﬁbers and in the early twenties for projection ﬁbers
[41, 42], we included both the linear and quadratic effects
of age in the model. The quadratic age term was centered
to avoid collinearities with the linear age term. In addi-
tion, because females and males show different trajec-
tories of DTI measures across development [43], sex was
accounted for in the model. Cohen’s d effect sizes for
diagnosis were computed. Subsequently, an inverse-
variance weighted mixed-effect meta-analysis [44] to
combine individual site effect sizes, as in [40].
A pooled, or mega-analytic, approach was also con-
ducted. As multiple factors can affect the distribution of
DTI measures [45–47], additional harmonization of DTI
measures can be advantageous when conducting studies
pooling dMRI data from different protocols. We used the
COMBAT algorithm [48] to harmonize data across sites for
each DTI measure (FA, MD, RD, and AD) for each WM
ROI. This algorithm uses an empirical Bayes framework to
estimate additive and multiplicative site effects. It has been
used previously for harmonization of multisite DTI data,
and has been shown to perform better than several other
methods for modeling and removing inter-site variability
[48]. Next, group differences were assessed using the same
model tested in the meta-analysis. Finally, the diagnosis-by-
age interaction effect term was included in the mega-
analytic model to test whether effects of age differed in
22q11DS probands relative to HC.
We used the Benjamini & Hochberg method to control
for the family wise error rate [49]. The percentage of tol-
erated false positives was 5% (q < 0.05). Critical p-values
were calculated for each set of models, speciﬁcally: (1)
meta-analysis; (2) mega-analysis; and (3) mega-analysis
including diagnosis-by-age interaction. Effect sizes were
derived as explained in Supplemental Methods 3.
In addition, given previous ﬁndings of nonlinear tra-
jectories of DTI-derived measures with respect to age in
healthy individuals (5–82 years) [50], we ﬁt a Poisson
nonlinear model for age for each group separately (HC
and 22q11DS) for each WM ROI and for each DTI-
derived measure, to further investigate age effects. We
used the previously harmonized data (see above COM-
BAT harmonization), to reduce site effects. We measured
the age of peak FA and age of minimum MD, RD, and AD
as in Lebel et al. [50] and compared both groups using a
two-tailed t-test for means with outlier removal (α=
0.05). Thereafter, we calculated the percent change of
each DTI measure for each ROI from age 6 (minimum age
in both groups) to peak/minimum, and from peak/mini-
mum to age 46 and 52 (maximum age for 22q11DS and
HC, respectively). We compared the percent changes of
each DTI measure for all ROIs between 22q11DS and HC
groups by using Yuen’s method with bootstrap-t for
trimmed means (α= 0.05) [51].
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Inﬂuence of psychotic disorder, deletion size, and IQ on DTI
measures
To assess potential differences in WM architecture as a
function of clinical and genetic variability, we examined the
effects of psychotic illness (35 with psychotic disorder vs
191 without psychosis) and deletion size (206 AD vs 15
AB) on DTI measures, within individuals with 22q11DS. In
addition, given that IQ is a group-associated variable, we
examined partial correlations with IQ within the 22q11DS
(N= 304) and HC groups (N= 102) separately. For these
analyses the DTI measures for each ROI were included as
dependent variables. Age, [age-mean(age)]2 and sex were
included as covariates. FDR correction was performed as
speciﬁed above (Section “Effects of 22q11DS and age on
DTI-derived measures”).
There is a strong association between age and psychosis
onset [5], and there was a signiﬁcant difference in mean age
between 22q11DS cases with and without psychosis (see
Supplementary Table S2b). To assess the effect of psy-
chosis within the 22q11DS group, we used a local non-
parametric ANCOVA method [51] covarying for age (see
Supplemental Methods 4). This approach allowed for a
controlled test within age subgroups.
Next, in order to determine whether the microstructural
differences observed in 22q11DS-associated psychosis
overlap with those seen in idiopathic schizophrenia, we
compared our results for 22q11DS cases with and without
psychosis to schizophrenia case-control results from the
ENIGMA-Schizophrenia DTI Working Group [40], ana-
lyzed using the same protocols as in our study.
Results
Group differences across sites
We ﬁrst investigated whether there were consistent group
differences in WM microstructure between 22q11.2
deletion carriers and HC, using a standardized processing
pipeline. Equally important is to determine whether har-
monization of the data would allow pooled analyses for
further investigation of modulatory factors (psychosis,
deletion size, and IQ). Figure 2 shows group differences
for 22q11DS cases vs HC, from the meta-analysis and
mega-analysis: results were nearly identical, with similar
effect sizes. Effect sizes for each site are shown in Sup-
plementary Fig. 1. Most ROIs that signiﬁcantly differed
between 22q11DS and HC showed lower diffusivity
values (MD, AD, and RD) in 22q11DS subjects, but a
mixed pattern for FA. Signiﬁcantly higher FA in 22q11DS
cases relative to HC was observed in the tapetum (TAP),
genu (GCC), body and splenium of the corpus callosum
(BCC/SCC), the anterior and posterior limb of the internal
Fig. 1 Depiction of the 18 regions of interest (ROIs) of the Johns Hopkins University (JHU-ICBM) white matter atlas [39] that were analyzed in
the present study
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capsule (ALIC/PLIC), and posterior and superior corona
radiata (PCR/SCR), with moderate to large effect sizes (d
~ 0.3–0.8), for both analyses. In contrast, ROIs in asso-
ciation ﬁbers—the superior longitudinal fasciculus (SLF),
fornix/stria terminalis (FXST), and external/extreme cap-
sules (EC)—showed signiﬁcantly lower FA in 22q11DS
relative to HC (Supplementary Tables S6 and S7).
22q11DS subjects had signiﬁcantly lower MD than HC
in almost all ROIs investigated, with greatest effects (d ~
1.0) in the PCR and posterior thalamic radiation (PTR);
both contain mostly thalamo-cortical/cortico-thalamic and
corticofugal ﬁbers from posterior brain areas. For all 18
ROIs, MD was lower in 22q11DS, as was AD, for 15 of the
18 ROIs. Only the PLIC showed signiﬁcantly higher AD in
22q11DS relative to HC. For RD, all ROIs showing sig-
niﬁcant differences (15 of 18 ROIs) were lower in 22q11DS
than HC, with largest effects (d ~ 0.7) in the corpus callo-
sum and PCR (Supplementary Tables S6 and S7).
Age-associated effects
Given the wide age range (6–52 years), we wanted to
determine whether the development of WM appears delayed
or altered in 22q11DS. As shown in Supplementary
Table S6, there were highly signiﬁcant linear effects of age
for all indices for the majority of ROIs. FA was positively
associated with age, while the opposite pattern was found
for diffusivity values (MD, AD, and RD). There were also
signiﬁcant quadratic effects for almost all ROIs for FA,
MD, and RD. AD showed fewer signiﬁcant quadratic
effects, in both the meta- and mega-analyses. However, no
signiﬁcant age-by-diagnosis interactions were observed
(Supplementary Table S8). Given the sparse representation
of older adults, we also performed a mega-analysis with a
subsample of subjects under 30 years old to explore
potential age-by-diagnosis effects, which yielded similar
results (Supplementary Table S9).
We also investigated Poisson regression models to fur-
ther evaluate effects of age on WM development. These
models did not provide a substantially better ﬁt to the data
than the linear regression model used above, as determined
by the residual standard error of the ﬁts (see Supplementary
Tables S10–S12). As such, we retained the linear regression
models for our primary analyses, but report the additional
trajectory information obtained from the Poisson models
below.
Fig. 2 Results of meta- and mega-analyses including nine independent
datasets from the ENIGMA-22q11DS working group. The bar graphs
on the left side are organized based on the effect sizes for FA (positive
to negative, from left to right). The brain maps on the right side are
organized by rows, each one corresponding to respective bar graph on
the left. These show the JHU-ICBM atlas white matter ROIs that
passed multiple comparisons correction after meta-analysis. The model
tested was: DTI-ROI-measure= ß0+ ß1Diagnosis+ ß2Sex+ ß3Age
+ ß4Age2centered. WM: Average of all white matter JHU-ICBM ROIs
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Fig. 3 Results from the local nonparametric ANCOVA analysis com-
paring 22q11DS subjects with psychotic disorder (N= 35) vs those
with no lifetime history of psychotic symptoms (N= 191). Shown here
are the results for DTI indices that signiﬁcantly differed between 22q-
Psychosis vs 22q-No Psychosis: AD in the ALIC, CGC, PTR, SLF, and
SS, RD in GCC, and MD in the GCC and PLIC. All analyses were
performed on 25 design points corresponding to different age bands.
Vertical red lines correspond to the ages at which these DTI measures
(AD, MD, and RD) signiﬁcantly differed between subjects with
22q11DS with and without psychosis (Supplementary Table S16)
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Scatterplots for the nonlinear Poisson ﬁts of age per
ROI for each DTI-derived measure are displayed in
Supplementary Figs. S2–S5. There were fewer ROIs with
signiﬁcant peak/minimum estimates in the 22q11DS
group, across all DTI indices (see Supplementary
Tables S13 and S14). Generally, those ROIs without
signiﬁcant peak/minimum estimates have linear rather
than exponential growth and decay trajectories. When
comparing the mean age of peak FA (across ROIs)
between HC and 22q11DS, average peak FA was sig-
niﬁcantly older in 22q11DS. We found a signiﬁcantly
older mean age at minimum RD in 22q11DS, but no
differences in mean ages at minimum MD and AD.
The mean percent change of FA after its peak and
mean percent change of RD and MD after their minima
were also signiﬁcantly greater in HC vs 22q11DS, with no
differences in AD (Supplementary Table S15).
Inﬂuence of psychosis
Are the deletion-related WM changes more severe in those
with psychotic disorder? Relative to 22q11DS subjects
without psychosis, 22q11DS subjects with psychotic dis-
order showed overall lower diffusivity values, with sig-
niﬁcantly lower AD in the ALIC and PTR, both
predominantly containing thalamic radiation ﬁbers, in the
cingulum of the cingulate gyrus (CGC) and the SLF, which
mostly contain fronto-parietal and fronto-temporal associa-
tion ﬁbers, and the sagittal stratum (SS), which contains both
posterior thalamic projection and temporal association ﬁbers.
22q11DS-Psychosis was also associated with signiﬁcantly
lower RD and MD in the GCC, which contains callosal
ﬁbers, and signiﬁcantly lower MD in the PLIC, where the
superior thalamic radiation and cortico-pontine ﬁbers are the
major constituents. These differences were seen primarily
between ages 20 and 26 for most ROIs; some ROIs (ALIC,
PTR, and SS) showed differences by age 16–17 (Fig. 3 and
Supplementary Table S16). Overall, these ﬁndings conﬁrm
that WM differences detected by DTI diffusivity measures
are more severe in 22q11DS patients with psychotic dis-
order, and are particularly evident in young adulthood.
Comparison of WM microstructure in 22q11DS-
psychosis to idiopathic schizophrenia
Next, we compared our results for 22q11DS cases with and
without psychosis to schizophrenia case-control results
(2359 HC vs 1963 schizophrenia patients) [40], plotted
together for visualization purposes (Fig. 4). Effects for
22q11DS cases with and without psychosis differed mark-
edly from those observed for idiopathic schizophrenia
relative to HC. Speciﬁcally, while patients with 22q11DS-
psychosis tended toward higher FA and lower diffusivity
values compared to 22q11DS individuals without psy-
chosis, patients with idiopathic schizophrenia showed
overall lower FA across tracts and increased diffusivity
values relative to HC, particularly for MD and RD.
Inﬂuence of deletion type and IQ
Does the extent of the deletion affect WM microstructure?
Subjects with the large A–D deletion showed a trend toward
lower AD in the anterior corona radiata and EC, and higher
FA in the TAP; however, there were no statistically sig-
niﬁcant differences in relation to deletion size, after multiple
comparisons correction (see Supplementary Fig. S6 and
Supplementary Table S17).
In addition, regarding relationships between DTI indices
and cognitive abilities, HC showed trends toward positive
correlations of MD, RD, and AD in multiple ROIs with IQ,
and a trend toward a negative correlation of FA with IQ in
the TAP. Within 22q11DS cases, ﬁndings were similar, but
higher IQ was associated with signiﬁcantly higher AD in
the PTR, which contains mainly posterior cortico-thalamic
and thalamo-cortical ﬁbers. There was also a trend toward
higher AD in the average WM, genu of the CC, and SS
being associated with higher IQ in 22q11DS (Supplemen-
tary Fig. S7, Supplementary Table S18). While these rela-
tionships were not signiﬁcant when corrected for multiple
comparisons, the overall pattern of ﬁndings suggests that
relationships between WM microstructure and cognition
need further investigation in 22q11DS relative to typically
developing controls.
Discussion
This is the largest study to date of WM microstructure in
22q11DS (334 22q11DS cases and 260 HC), assessed by
DTI. Our analysis pipeline [37, 40] allowed for coordinated
prospective meta- and mega-analyses of the data across
sites, unlike traditional meta-analyses that combine statis-
tical results from the literature. This approach addresses, for
the ﬁrst time, issues of low power due to small sample sizes
and variable analysis protocols that contribute to hetero-
geneity and lack of clarity in DTI studies to date.
In contrast to ﬁndings in many neuropsychiatric dis-
orders [40, 52], our ﬁndings revealed overall lower DTI
diffusivities (AD, RD, and MD) in 22q11DS compared to
HC, with regionally varying directions of effect for FA.
Higher FA, lower RD and AD (and consequently, lower
MD) appear to be the hallmark of microstructural alterations
in the major WM tracts in 22q11DS, especially in the
commissural ﬁbers of the corpus callosum. While this may
suggest greater myelination [13], we must be cautious in
applying this interpretation to our ﬁndings, given that dMRI
J. E. Villalón-Reina et al.
cannot directly index the degree of myelination [53]. Ani-
sotropy does not only depend on the presence of myelin in
the WM, as it has been demonstrated in unmyelinated tracts
[54] and is also sensitive to axonal density. RD is sensitive
to axonal density and amount of extracellular space, and
AD to axonal diameter and organization [12, 55]. Moreover,
since axonal density and myelination are correlated [54, 56],
it is not possible to disentangle one from another when
interpreting FA and RD differences between populations.
We postulate that the observed group differences may result
from an increase in the cumulative cellular membrane cir-
cumference [57] in 22q11DS (attributable to differences in
axon composition, myelination and/or reactive astrocytes),
which hinders diffusion perpendicularly to the WM tracts,
hence increasing anisotropy and decreasing RD.
Our ﬁndings of higher FA in 22q11DS relative to con-
trols in ROIs in commissural tracts (TAP, GCC, BCC, and
SCC), no detectable differences in ROIS where projection
ﬁbers predominate (RLIC, SS, PTR, and SFO), and lower
FA in ROIs in long association tracts (EC, SLF, FXST) are
consistent with ﬁndings in the mouse model of 22q11DS
[9]. Speciﬁcally, this study found that proliferation of basal,
but not apical progenitors is disrupted, and subsequently the
frequency of projection neurons in layers 2/3, but not layers
5/6, is altered. Commissural and long association ﬁbers
originate primarily from projection neurons, i.e., pyramidal
neurons in the outer layers 2/3, whereas corticofugal and
cortico-thalamic projection ﬁbers tend to originate from
pyramidal cells in cortical layers 5/6. Moreover, our results
suggest that the nature of WM disruptions may differ
Fig. 4 Comparison of effect sizes in this study, to those from the
ENIGMA-Schizophrenia DTI Working Group using similar methods
(2359 healthy controls vs 1963 schizophrenia patients from 29 inde-
pendent studies; Kelly et al. [40]; blue triangles) to 22q11DS probands
with and without psychosis (red circles). Positive effect sizes: 22q-
Psychosis > 22q-No psychosis OR schizophrenia patients > healthy
controls. Negative effect sizes: 22q-No psychosis > 22q-psychosis OR
healthy controls > schizophrenia patients. We note, as stated in the
ENIGMA-DTI protocol [38], that the IFO and UNC in the original
JHU atlas from FSL, were later renamed the UNC and TAP, respec-
tively. Here we matched the ENIGMA-Schizophrenia results with the
updated atlas
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between callosal and long association ﬁbers in 22q11DS,
but advanced microstructural MRI techniques may be
necessary to disentangle these differences. As such, these
cross-species ﬁndings collectively suggest a potential neu-
robiological model in which haploinsufﬁciency at the
22q11.2 locus leads to disruptions of speciﬁc aspects of
early brain development, and subsequent changes in neural
circuitry that likely elevate risk for neuropsychiatric dis-
orders in 22q11DS patients.
We speculate that our ﬁndings may be related to three
types of histopathological alterations in the WM of
22q11DS patients, all of which could reduce diffusivity.
First, a recent neuropathology study of a 3-month-old infant
with 22q11DS reported decreased neuronal frequencies in
outer cortical layers and increased neuronal frequencies in
deeper cortical layers [9]. This is closely related to ﬁndings
in the LgDel 22q11.2 mouse model mentioned above [9].
Pyramidal neurons of cortical layers 2/3 generate a sub-
stantial portion of the cortico-cortical axonal projections
between association areas [58]. These axons are present in
most of the WM ROIs included in this study. Consequently,
target-to-origin signaling between cortical association areas
(cortico-cortical projections) may be disrupted in 22q11DS,
affecting the necessary cues to initiate proper axonal dif-
ferentiation [59, 60], ultimately affecting the development
of a typical distribution of axonal diameters [61–63], and
therefore altering RD and AD in WM bundles. Moreover,
the PLIC was the only ROI showing higher AD in
22q11DS. AD has been associated with axonal diameter
changes and axonal tortuosity in rats [12, 55]. PLIC is the
only ROI in this study that contains mostly corticofugal
ﬁbers, which primarily derive from cortical layers 5/6
[39, 58], suggesting that the axonal size distribution within
ﬁber bundles originating in the deeper cortical layers may
differ from those originating in the outer cortical layers
[61, 63]. Further studies of animal models and postmortem
human brain tissue may shed light on this.
Second, DTI abnormalities may also reﬂect gliotic
changes secondary to microvascular insults. Postmortem
ﬁndings in 22q11DS adults indicate both deep WM gliosis
associated with cerebrovascular changes [64]. Gliosis—
occurring as brain reacts to microvascular injuries—has
been associated with increased anisotropy in a mouse brain
injury model [65]. Third, DTI measures may be affected by
ectopic neurons in WM that may result from neuronal
migration defects during early development [66]. These
have been reported in both neuropathologic [64, 67, 68] and
neuroimaging studies of 22q11DS patients [69, 70]. While
we did not detect any heterotopias in our cohort, subtle
microscopic ones may be detected only via histology.
The age trajectories of FA, MD, RD, and AD, as well as
peak and minimum age estimates of our control sample,
were similar to those reported previously [50]. However,
22q11DS patients showed an older mean age of both peak
FA and minimum RD; correspondingly, they also showed
smaller percent changes for FA and MD after peak and
minimum ages, respectively. As noted above, these ﬁndings
may indicate a delay in maturation secondary to altered
axonal diameters and organization in the deep WM, which
could be precursors of a delayed myelination process.
Conversely, a smaller percent change after maturation
(indicated by peak FA and minimum RD) may be indicative
of underlying organizational changes in WM that abnor-
mally hinder diffusion and may result from gliotic changes,
as has been reported in adult post-mortem 22q11DS brain
tissue [64]. Nevertheless, despite the harmonization proto-
col interpretive caution is warranted because the age dis-
tribution was variable across sites and data points were
rather sparse in the older age ranges.
Consistent with some single-site studies suggesting
inverse correlations between psychotic symptom severity in
22q11DS and diffusivity in the CC and long association
tracts [25, 29–31, 33], we found lower RD and MD in those
with psychosis in the genu of the CC, and lower AD in long
association tracts such as the SLF and CGC. Interestingly,
signiﬁcantly lower AD was found in ROIs with pre-
dominantly cortico-thalamic and thalamo-cortical ﬁbers
such as the ALIC, SS and the PTR. A previous single-site
tractometry study found signiﬁcant associations between
higher FA and lower RD in the ALIC with positive pro-
dromal symptoms [29]. Future studies should prospectively
investigate the role of the major thalamic projection tracts in
the emergence and progression of psychotic symptoms in
22q11DS.
Notably, WM microstructural alterations in 22q11DS
with psychosis showed a largely opposite pattern from those
seen in idiopathic schizophrenia, involving primarily FA
being higher (rather than lower), and lower (rather than
higher) diffusivity measures. A previous single site study of
22q11DS and youth at clinical high risk for psychosis
reported this directionally opposite pattern as well [24]. This
is in contrast to ﬁndings for cortical gray matter, in which
22q11DS patients with psychosis showed highly signiﬁcant
overlap with idiopathic schizophrenia, in terms of promi-
nent cortical thinning in fronto-temporal regions [35]. Thus,
our ﬁndings suggest that patterns of neuroanatomic overlap
in 22q11DS-associated vs. idiopathic psychosis markedly
differ for gray and WM, and suggest that different WM
phenotypes may lead to similar downstream clinical out-
comes. Our ﬁndings of altered AD in 22q11DS, more
extreme in those with psychosis, may indicate altered axo-
nal diameter and increased tortuosity of WM tracts [12, 55].
Numerous smaller, tortuous axons in key connections
between cortical association areas may lead to altered WM
maturation, structural dysconnectivity and possibly psy-
chosis. In idiopathic schizophrenia, WM degeneration
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(demyelination and loss of axons with larger diameters)
may also lead to disrupted axonal morphology that similarly
results in structural dysconnectivity between cortical
association areas.
We did not ﬁnd consistent effects of deletion size on
WM architecture, and found little evidence that the rela-
tionship between WM microstructure and IQ differed
between 22q11DS cases and HC. Sample size was quite
limited for the A–B deletion type, and imaging protocols
varied across sites, which may have affected our results.
In addition, given highly variable psychotropic medica-
tions and medical comorbidities in 22q11DS patients,
their effects could not be systematically investigated here.
Previously, in a sample including many of the same par-
ticipants as in the current analysis, we found that psy-
chotropic medication was not signiﬁcantly associated
with cortical thickness or cortical surface area in 22q11DS
patients [35]. Additionally, prior studies of patients with
idiopathic schizophrenia found that WM changes detected
by DTI were not attributable to antipsychotic medication
[40, 71].
Future studies with multishell acquisitions and novel
biophysical models may resolve the contribution of the
intra- and extra-axonal volume fractions and axonal dia-
meters to these abnormalities [72, 73]. Quantitative mag-
netization transfer [74] and perfusion MRI acquisitions [75]
may help clarify any myelin abnormalities or underlying
brain microvascular pathology in 22q11DS.
Collectively, our ﬁndings indicate large effects of the
22q11.2 deletion on WM microstructure. Diffusivity was
more consistently affected than FA. In animal models,
disruptions to predominantly cortico-cortical and cortico-
thalamic/thalamo-cortical connections in 22q11DS may be
attributable to disrupted early neurogenesis. Future trans-
lational studies will help to determine the neurobiological
underpinnings of these alterations.
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